Molecular tracking devices quantify antigen distribution and archiving in the murine lymph node
- University of Colorado Anschutz Medical Campus, United States
Abstract
The detection of foreign antigens in vivo has relied on fluorescent conjugation or indirect read-outs such as antigen presentation. In our studies, we found that these widely used techniques had several technical limitations that have precluded a complete picture of antigen trafficking or retention across lymph node cell types. To address these limitations, we developed a 'molecular tracking device' to follow the distribution, acquisition, and retention of antigen in the lymph node. Utilizing an antigen conjugated to a nuclease-resistant DNA tag, acting as a combined antigen-adjuvant conjugate, and single-cell mRNA sequencing we quantified antigen abundance in lymph node. Variable antigen levels enabled the identification of caveolar endocytosis as a mechanism of antigen acquisition or retention in lymphatic endothelial cells. Thus, these molecular tracking devices enable new approaches to study dynamic tissue dissemination of antigen-adjuvant conjugates and identify new mechanisms of antigen acquisition and retention at cellular resolution in vivo.
Data availability
Raw and processed data for this study have been deposited at NCBI GEO under accession GSE150719. A reproducible analysis pipeline is available at https://github.com/rnabioco/antigen-tracking.
-
Molecular tracking devices quantify antigen distribution and archiving in the lymph nodeNCBI Gene Expression Omnibus, GSE150719.
-
Transcriptional basis of mouse and human dendritic cell heterogeneity revealed by single-cell profilingNCBI Gene Expression Omnibus, GSE137710.
-
ImmGen Microarray Phase 1NCBI Gene Expression Omnibus, GSE15907.
-
Single-cell RNA sequencing of lymph node stromal cells reveals niche-associated heterogeneityNCBI Gene Expression Omnibus, GSE112903.
-
Single-cell RNA-seq of the mouse lymph node lymphatic vasculature: Droplet-seqNCBI Gene Expression Omnibus, GSE145121.
-
ImmGen ULI: Systemwide RNA-seq profiles (#1)NCBI Gene Expression Omnibus, GSE109129.
Article and author information
Author details
Beth Ann Jiron Tamburini
Funding
National Institutes of Health (R01 AI121209)
- Beth Ann Jiron Tamburini
University of Colorado Department of Medicine Outstanding Early Career Scholar and RBI Clinical Scholar Award (Outstanding Early Career Scholar and RBI Clinical Scholar Award)
- Beth Ann Jiron Tamburini
American Cancer Society (Post-doctoral Fellowship)
- Shannon M Walsh
National Institutes of Health (T32 AI007405)
- Erin D Lucas
National Institutes of Health (R35 GM119550)
- Jay R Hesselberth
National Institutes of Health (T32 AI074491)
- Ryan M Sheridan
National Institutes of Health (R21 AI155929)
- Jay R Hesselberth
- Beth Ann Jiron Tamburini
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: All animal procedures were approved by the Institutional Animal Care and Use Committee at the University of Colorado under protocol number 00067.
Copyright
© 2021, Walsh et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,303
- views
-
- 319
- downloads
-
- 23
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Molecular tracking devices quantify antigen distribution and archiving in the murine lymph node
eLife 10:e62781.
https://doi.org/10.7554/eLife.62781
Further reading
-
- Cell Biology
Dynamic interactions between gut mucosal cells and the external environment are essential to maintain gut homeostasis. Enterochromaffin (EC) cells transduce both chemical and mechanical signals and produce 5-hydroxytryptamine to mediate disparate physiological responses. However, the molecular and cellular basis for functional diversity of ECs remains to be adequately defined. Here, we integrated single-cell transcriptomics with spatial image analysis to identify 14 EC clusters that are topographically organized along the gut. Subtypes predicted to be sensitive to the chemical environment and mechanical forces were identified that express distinct transcription factors and hormones. A Piezo2+ population in the distal colon was endowed with a distinctive neuronal signature. Using a combination of genetic, chemogenetic, and pharmacological approaches, we demonstrated Piezo2+ ECs are required for normal colon motility. Our study constructs a molecular map for ECs and offers a framework for deconvoluting EC cells with pleiotropic functions.
-
- Cell Biology
Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.
